Benzinga | Aug 4, 2020 04:22PM EDT

Deciphera Pharmaceuticals Q2 EPS $(1.20) Beats $(1.37) Estimate, Sales $7.10M Beat $900.00K Estimate

Deciphera Pharmaceuticals (NASDAQ:DCPH) reported quarterly losses of $(1.20) per share which beat the analyst consensus estimate of $(1.37) by 12.41 percent. This is a 114.29 percent decrease over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $7.10 million which beat the analyst consensus estimate of $900.00 thousand by 688.89 percent. This is a 71.60 percent decrease over sales of $25.00 million the same period last year.